RecalledThisWeek Search
High risk Medical DevicesClass II

Medtronic MiniMed 720G Insulin Pump Recall

MiniMed 720G Insulin Pump (MMT-1809, MMT-1810, MMT-1859, MMT-1860, MMT-1867)

Updated February 13, 2026

Medtronic MiniMed insulin pumps can deliver too much or too little insulin depending on the pump's height relative to the infusion site. Over-delivery can cause dangerously low blood sugar, while under-delivery can cause dangerously high blood sugar, with both potentially leading to serious complications.

Is the Medtronic MiniMed, Inc. recalled? Yes. This product was recalled by FDA on February 13, 2026. Details below.

What is recalled

Medtronic MiniMed 720G Insulin Pump models MMT-1809, MMT-1810, MMT-1859, MMT-1860, and MMT-1867, including all Medtronic MiniMed infusion pumps in the Paradigm series, 600 series, and BLE 700 series.

Am I affected

You're affected if you use a Medtronic MiniMed infusion pump from the Paradigm series, 600 series, or BLE 700 series (check your pump's model number: MMT-1809, MMT-1810, MMT-1859, MMT-1860, or MMT-1867).

What to do right now

Contact Medtronic MiniMed immediately to discuss your pump and learn about a fix. Be aware that insulin delivery can change based on how high or low your pump sits relative to your infusion site. Monitor your blood sugar closely and watch for signs of very low blood sugar (confusion, shakiness, sweating) or very high blood sugar (excessive thirst, fatigue). Seek immediate medical care if you experience severe symptoms.

The hazard

All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.

Brands affected

Medtronic MiniMed, Inc.
Source
FDA
Category
Medical Devices
Recall ID
fda-Z-1745-2026
Classification
Class II
Recalled
February 13, 2026
Read the official notice

Get free recall alerts

New Medical Devices recalls, the moment they post.

Free forever. Unsubscribe anytime. We never sell your data.

More Medical Devices recalls